SCHWARTZ; Martin A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHWARTZ; Martin A..The latest application filed is for "anti-cancer compounds targeting ral gtpases and methods of using the same".

Company Profile

2.14.12

SCHWARTZ; Martin A. - Earlysville VA
SCHWARTZ; Martin A. - Milford CT
Schwartz; Martin A. - Tallahassee FL
Schwartz; Martin A. - Poway CA
Schwartz; Martin A. - Santa Monica CA
Schwartz; Martin A. - Tarzana CA
Schwartz; Martin A. - Chatsworth CA
Schwartz; Martin A. - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-cancer Compounds Targeting Ral Gtpases And Methods Of Using The Same App 20200270263 - THEODORESCU; Dan ; et al.	2020-08-27
Anti-cancer compounds targeting ral GTPases and methods of using the same Grant 10,689,392 - Theodorescu , et al.	2020-06-23
Anti-cancer Compounds Targeting Ral Gtpases And Methods Of Using The Same App 20160280715 - THEODORESCU; Dan ; et al.	2016-09-29
Anti-cancer compounds targeting Ral GTPases and methods of using the same Grant 9,353,121 - Theodorescu , et al. May 31, 2	2016-05-31
Compositions And Methods For Inhibiting Chemoresistance In Cancer And Improving Response To Therapy App 20160067314 - SCHWARTZ; Martin A. ; et al.	2016-03-10
Anti-cancer Compounds Targeting Ral Gtpases And Methods Of Using The Same App 20140315894 - Theodorescu; Dan ; et al.	2014-10-23
Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors Grant 8,404,866 - Schwartz , et al. March 26, 2	2013-03-26
Substituted Heterocyclic Mercaptosulfonamide Metalloprotease Inhibitors App 20110144179 - Schwartz; Martin A. ; et al.	2011-06-16
Methods and compositions for inhibition of vascular permeability Grant 7,838,490 - Schwartz , et al. November 23, 2	2010-11-23
Methods and Compositions for Inhibition of Vascular Permeability App 20090220487 - Schwartz; Martin A. ; et al.	2009-09-03
Compositions and Methods for Inhibiting Leukocyte Function App 20090022712 - Reutershan; Joerg ; et al.	2009-01-22
Method of inhibiting vascular permeability Grant 7,442,681 - Schwartz , et al. October 28, 2	2008-10-28
Peptide-based angiogenesis inhibitors and methods of use thereof Grant 7,125,849 - Cheresh , et al. October 24, 2	2006-10-24
Method of inhibiting vascular permeability App 20050233965 - Schwartz, Martin A. ; et al.	2005-10-20
Peptide-based angiogenesis inhibitors and methods of use thereof App 20040138133 - Cheresh, David A. ; et al.	2004-07-15
Methods For Use For Integrin B1c Cell Growth Inhibitor App 20020102240 - SCHWARTZ, MARTIN A. ; et al.	2002-08-01
Analog/digital voice storage cellular telephone Grant RE34,976 - Helferich , et al. June 20, 1	1995-06-20
Analog/digital voice storage cellular telephone Grant 5,003,576 - Helferich March 26, 1	1991-03-26
Analog/digital data storage system Grant 4,905,003 - Helferich February 27, 1	1990-02-27
Variable speed transmission recording and retrieval of data Grant 4,864,301 - Helferich September 5, 1	1989-09-05
Synthesis of derivatives of codeine and other 3-O-alkylmorphines Grant 4,795,813 - Schwartz January 3, 1	1989-01-03
Radio-labelled cross-linking reagents Grant 4,487,838 - Hynes , et al. December 11, 1	1984-12-11
Process for the preparation of an N-substituted 3-O-alkyl-14-hydroxynormorphinone derivative Grant 4,472,253 - Schwartz September 18, 1	1984-09-18

Company Registrations

NCAGE Code	4WFA8	SCHWARTZ, MARTIN A
CAGE Code	4WFA8	SCHWARTZ, MARTIN A
DUNS	808022599	SCHWARTZ, MARTIN A

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.